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A B S T R A C T
Purpose: We describe the inﬂuence of vagus nerve stimulation (VNS) with standard mode and rapid
cycling mode on sleep related breathing in two patients with epilepsy.
Methods: Two VNS treated patients underwent digital video-polysomnography for three nights (night 1:
rapid cycling mode; night 2: standard mode; night 3: off mode).
Results: In patient 1, on off mode, apnea-hypopnea index (AHI) was 11.1/h, respiratory effort-related
arousal index (RERAI) 0.9/h, ﬂow limitation index (FLI) 0.9/h and oxygen desaturation index (ODI) 10.2/h.
On standard mode, AHI was 5.5/h, RERAI 1.7/h, FLI 4.1/h and ODI 5.5/h. On rapid cycling mode, AHI was
10.4/h, RERAI 7.9/h, FLI 17.3/h and ODI 10.3/h. In patient 2, on off mode, AHI was 1.6/h, RERAI 0.8/h, FLI
2.2/h and ODI 0/h. On standard mode, AHI was 2.9/h, RERAI 2.4/h, FLI 2.6/h and ODI 2.9/h. On rapid
cycling mode, AHI was 0.7/h, RERAI increased to 15.4/h, FLI to 52.0/h and ODI was 0.7/h.
Conclusions: The number of RERAs as well as the number of ﬂow limitations were higher with the rapid
cyclingmode compared to standardmode and stimulation off andmight be related to the higher impulse
frequency.
 2008 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Vagus nerve stimulation (VNS) is an effective adjunct treatment
for medically refractory epilepsy.1,2 It is hypothesized, that the
synchronous electrical stimuli interrupt seizures via the vagus
nerve projections in the nucleus tractus solitarius to the brainstem
formations, including parabrachial nucleus and locus coerulus.1
Several studies have been published analyzing the effect of
stimulation parameters on seizure frequency in refractory
epilepsy.3,4 Several stimulation modes have been applied (stan-
dard: stimulation for 30 s followed by a stimulation-free period of
5 min, pulse width of 500 ms) and a signiﬁcantly higher efﬁcacy of
VNS with the rapid cycling mode (cycles of 7-s stimulation with a
stimulation-free interval of 12 s) have been described).3,4 Efﬁcacy
appears to increase over time. In general, one third of the patients
show a >50% reduction of seizure frequency; one third show a 30–
50% seizure reduction, and one third of patients show no response.
Few patients become seizure-free. Side effects during stimulation
are mainly voice alteration, coughing, throat paraesthesia and
discomfort.2 Frequent side effects of long-term VNS treatment
include cough, voice alteration, dyspnea and paresthesia.5* Corresponding author. Tel.: +43 512 504 23877; fax: +43 512 504 24260.
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doi:10.1016/j.seizure.2008.12.003Moreover, during sleep, an increased apnea-hypopnea index
(AHI) was shown.5,6 Besides, two case studies have reported VNS
related tachypnea and apnea.7,8
Analysis of different settings (standard mode versus rapid
cycling mode) of VNS on sleep related breathing, however, has not
been performed.
We investigated the inﬂuence of different settings of VNS
(standard mode versus rapid cycling mode versus stimulation off)
on sleep related breathing in two patients with focal epilepsy.
2. Methods
2.1. Patients
Twomale patients withmedically refractory focal epilepsy who
had undergone VNS device implantation previously participated in
this study. The vagus nerve stimulation (VNS) device (Neurocy-
bernetic Prosthesis System; Cyberonics Inc., Houston, Texas, USA)
was implanted according to standard methodology.5 Patient 1 was
a 35-year-old man diagnosed as cryptogenic epilepsy with simple
partial (SP), complex partial (CP) and generalized tonic clonic
seizures (TC). At the time of polysomnography (PSG) he was
treated with levetiracetam 3000 mg, phenobarbitone 400 mg and
carbamazepine 1650 mg per day. Patient 2 was a 36-year-old man
with symptomatic epilepsy after fronto-temporal osteoplastic
craniotomy for craniopharyngioma in 1978. He had SP, CP andvier Ltd. All rights reserved.
Table 1
Sleep variables of patients 1 and 2.
VNS parameter Patient 1 Patient 2
Off SM RCM Off SM RCM
Time in bed (TIB) (min) 490.5 477.0 481.5 488.0 475.0 481.0
Sleep period time (SPT) (min) 471.5 465.5 463.0 486.5 471.0 473.5
Sleep latencya (min) 12.0 11.5 18.5 1.5 4.0 7.5
REM latency (min) 183.0 76.5 71.5 90.0 167.5 101.0
Sleep efﬁciencyb (SE) (%) 80.0 71.5 89.5 95.4 97.5 84.8
Wakefulness (min SPT) 79.0 124.5 32.0 21.0 8.0 65.5
Stage 1 (min SPT) 95.0 44.5 81.0 68.0 71.0 50.5
Stage 2 (min SPT) 209.0 156.5 205.5 265.5 314.0 281.0
Stage 3 + 4 (min SPT) 56.5 107.0 107.5 43.5 12.0 40.0
REM (min SPT) 32.0 32.5 33.5 80.5 63.0 35.0
Time in body position (min)c
Supine position 392.5 328.5 333.5 280.5 177.5 334.5
Side position 0 0 71.5 177.0 282.5 72.5
a Sleep latency (ﬁrst epoch of stage 2 or three consecutive epochs of stage 1).
b Sleep efﬁciency: ratio of total sleep time to time in bed expressed in percent.
c Prone position was not registered in both patients.
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3000 mg and phenytoin 600 mg per day.
At admission to the hospital, both patients were on standard
mode VNS setting consisted of on/off cycles of 30 s every 5 min,
with each on cycle consisting of 500-ms duration pulses at 30 Hz;
output current was increased as tolerated to a intensity of
0.75 mA.
2.2. Polysomnography
Polysomnographies were performed at the Sleep Disorders
Unit, Department of Neurology, Innsbruck Medical University.
Digital polysomnography (Schwarzer Brainlab for Windows
Version 4.00; Munich, Germany) included electroencephalography
(EEG) (C3-A2, C4-A1, O1-A2, O2-A1), horizontal and vertical
electrooculogram (EOG), bipolar surface electromyography of
mental, submental, and both tibialis anterior muscles. Cardior-
espiratory monitoring consisted of nasal and oral airﬂow
(thermocouple, nasal pressure cannula), tracheal microphone,
thoracic and abdominal respiratory effort (Piezo), ﬁnger oximetry
and one lead electrocardiogram. Infrared video was recorded
during the whole night and digitally stored.
Since the new standard criteria of the American Academy of
Sleep Medicine (AASM)9 were not published at time of investiga-
tion, sleep was recorded and visually scored in 30 s epochs
according to Rechtschaffen and Kales. The scoring of respiratory
events was retrospectively performed according to AASM 2007
standard criteria9 with the limitation that we used piezoelectric
registration instead of plethysmography for measuring thoracic
and abdominal respiratory effort. An obstructive apnea was
deﬁned as a 90% decrease in airﬂow from baseline amplitude for
10 s. A hypopnea was deﬁned as a 30% decrease in airﬂow for
10 s with a 4% oxygen desaturation from pre-event baseline.
The AHI for each night is the sum of apneas and hypopneas divided
per hour of sleep. Respiratory effort-related arousals (RERAs) were
scored as a increase of respiratory effort or ﬂattening of the nasal
pressure waveform with a duration of 10 s leading to an arousal
from sleep. RERA index (RERAI) for each night is the sum of RERAsTable 2
Respiratory variables and their association with arousals, body position and sleep stag
VNS parameter Patient 1
Off
Respiratory variables:
Apnea-hypopnea index (AHI) (Association with arousals, %) 11.1 (88.9)
Apnea index (AI) 4.0
Hypopnea index (HI) 6.1
RERA index (RERAI) 0.9
Flow limitation index (FLI) 0.9
Oxygen desaturation index (ODI) 10.2
Basal oxygen saturation (%) 97.0
Mean oxygen saturation (%) 94.3
Minimal oxygen saturation (%) 76.0
Respiratory variables in association with body position
Supine position
AHI 11.1
RERAI 0.9
Side position
AHI 0.0
RERAI 0.0
Respiratory variables in association with sleep stages:
Non-REM sleep
AHI 5.7
RERAI 0.8
REM sleep
AHI 60.0
RERAI 1.9divided per hour of sleep. Additionally, we scored ﬂow limitations
(FL) as a increase of respiratory effort or ﬂattening of the nasal
pressure waveform with a duration of 10 s which were not
associated with an arousal from sleep or an oxygen desaturation.
Flow limitation index (FLI) for each night is the sum of ﬂow
limitations divided per hour of sleep. The oxygen desaturation
index was calculated, as the sum of oxygen drops larger than 4%
from the immediately preceding baseline per hour of sleep. Both
patients underwent three nights of digital video-polysomnogra-
phy: the ﬁrst night on rapid cycling mode and the second night on
standard mode. Intensity of output current (0.75 mA) and 500-ms
duration pulses at 30 Hz were not changed between one PSG and
the other.
Additionally in both patients during hospitalization due to
pulse generator change a third PSG night on off-mode was
recorded. Both patients were on stable doses of antiepileptic
medications.es.
Patient 2
SM RCM Off SM RCM
5.5 (80.6) 10.4 (74.3) 1.6 (66.7) 2.9 (20.0) 0.7 (59.2)
0.0 7.1 0.0 0.0 0.0
5.5 3.3 0.4 2.9 0.7
1.7 7.9 0.8 2.4 15.4
4.1 17.3 2.2 2.6 52.0
5.5 10.3 0.4 2.9 0.7
92.0 94.0 96.0 96.0 95.0
93.9 94.1 96.4 94.1 96.0
77.0 74.0 92.0 81.0 88.0
5.5 13.1 0.6 6.4 0.9
1.7 8.6 1.0 2.0 14.5
0.0 1.7 0.7 0.8 0.0
0.0 7.6 0.0 2.8 19.9
1.2 7.9 0.3 2.9 0.3
1.9 7.9 0.8 2.9 16.0
48.5 41.2 0.7 3.8 5.1
0.0 0.0 0.7 0.0 10.3
Fig. 1. (a) The 120 s stage 2 sleep epoch out of the PSG night with VNS on standardmode in patient 2 shows one single vagus nerve stimulus as an artifact on the EMG channels
of mental and submental muscles (solid arrow) simultaneously with a respiratory event related arousal (RERA). (b) The 120 stage 2 sleep epoche of PSG night with VNS on
rapid-cycling-mode in patient 2 shows three vagus nerve stimuli (solid arrows) coinciding with respiratory effort-related arousals (RERAs).
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Sleep variables of each patient for all three PSG nights with the
different VNS settings are given in Table 1. In both patients, the
number of RERAs was higher with the rapid cycling mode
compared to standard mode and stimulation off. In line with this
ﬁnding, there was a striking increase of ﬂow limitations with the
rapid cycling mode. AHI and ODI were not effected by the different
settings of VNS. The RERA indices were not inﬂuenced by changes
of body position or different sleep stages. The effect of differential
settings of vagus nerve stimulation (VNS) on respiratory para-
meters as well as the association with arousals, body position and
sleep stages are shown in Table 2. An example of the close temporal
relationship between vagus nerve stimulus and RERAs is shown in
Fig. 1a and b. Fig. 1a shows a 120 s epoch recorded in patient 2with
VNS on standard mode during stage 2 sleep. A single vagus nerve
stimulus appears as an artifact in the EMG channels of mental and
submental muscles coinciding with a RERA. Fig. 1b corresponds toa 120 s stage 2 epoch obtained during the PSG with VNS on rapid
cycling mode in the same patient. Compared to the epoch during
PSG on standard mode three vagus nerve stimuli with simulta-
neous RERAs appears in the same timewindow. On the other hand,
at visual inspection, arousals also occurred – independently from
respiratory events – in the context of VN stimuli. Both patients had
no seizures during overnight recordings.
4. Discussion
This study shows that the mode of VNS (rapid cycling mode
versus standard mode versus stimulation off) differentially affects
respiration during sleep. We observed a striking increase of the
respiratory effort-related arousal index as well as the ﬂow
limitation index on rapid cycling mode compared to standard
mode or stimulation off. This effect was independent of pre-
existing mild sleep-related breathing disorder (patient 1), body
position, or sleep stage. We do not know if changing the output
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related breathing in our patients, since previous studies reported
divergent ﬁndings concerning the inﬂuence on respiration during
sleep by these VNS threshold settings. Malow et al. observed that
stimulus frequency reduction ameliorated VNS related apneas and
hypopneas,6 whereas there was no change in apneas and
hypopneas with stimulus intensities from 0.25 to 0.5 mA and
pulse widths of 500 and 125ms on standard mode.6 In contrast to
these ﬁndings, Zaaimi et al. reported a positive correlation between
stimulus intensity from 1 to 3 mA and thoracic distension
signals.10 However, intensity of output current (0.75 mA) and
500-ms duration pulses at 30 Hz were not changed between one
PSG and the other, but stimulation mode.
A close temporal relationship between RERAs and VNS
stimulation were observed (see Fig. 1a and b). We can only
speculate that the higher number of RERAs aswell as the number of
ﬂow limitations with rapid cycling mode compared to standard
mode is related to the higher impulse frequency. In rapid cycling
mode off to on time is 23–7 s (equivalent to 23.3% of stimulation
cycle time), in standardmode off to on time is 270–30 s (equivalent
of 10% of stimulation cycle time). In fact, while on rapid cycling
mode with more frequent stimulation cycles and higher total time
of stimulation on, in both patients a higher RERA index and FL
index was observed (see Table 1).
The RERAs might be caused by partial airﬂow limitation
induced by potential central and peripheral effects of VNS.6 In fact,
glottic dyskinesia has been observed during VNS by using
ﬁberoptic laryngoscopy.11
There was a high interindividual difference in the increase of
RERAs fromoffmode to rapid cyclingmode (approximately 10-fold
versus 20-fold increase). Even more striking was the increase of
ﬂow limiations, although the clinical relevance is uncertain. One
possible explanation may be the different antiepileptic drug
regimen. In fact, patient 2 was on phenytoine which was found to
impair peripheral chemoreceptor responses to hypoxia in the
animal model.12
There are several potential limitations of our study. First, it is a
preliminary investigation in only two patients. Second, we used
piezoelectric registration for measurement of respiratory effort
instead of the gold standard plethysmography.9 Third, we only
scored respiratory event related arousals. We did not perform an
analysis of VN stimulus related arousals since in polysomnography
the stimulus was not always visualized. In summary, these casessuggest that respiration during sleep should be carefully inves-
tigated in patients who undergo VNS stimulation especially in
rapid cycling mode. In case of a signiﬁcant increase of RERAs as
well as ﬂow limiations speciﬁcally if it reaches clinical signiﬁcance,
a change in VN stimulus mode or treatment with nasal CPAP
should be considered. Further studies with larger number of
patients will be needed to investigate the inﬂuence of different
VNS modes not only on sleep breathing, but also on arousals in
general (cycling alternating pattern) and daytime sleepiness.
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